Adolescents With Type 1 Diabetes Using Dapagliflozin as an Adjunct-to-Insulin: Perspectives on Experiences of Clinical Trial Participation
Samantha J. Anthony, Enid K. Selkirk, Sarah J. Pol, Jia Lin et autres
OBJECTIVES: The Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration (ATTEMPT) study evaluated the impact of sodium-glucose cotransporter-2 inhibitors (SGLT2i) as an adjunct-to-insulin therapy. Adolescent experiences were explored to gain their informed perspective on adjunct-to-insulin medications as a potential …
ca, us, au, nl (code pays fourni par la source)
1 citation
Endocrine Practice